| Host: | Rabbit |
| Applications: | WB/ELISA |
| Reactivity: | Human/Mouse |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Clonality : | Polyclonal |
| Conjugation: | Unconjugated |
| Isotype: | IgG |
| Formulation: | PBS with 0.01% Thimerosal, 50% Glycerol, pH 7.3. |
| Purification: | Affinity purification |
| Concentration: | Lot specific |
| Dilution Range: | WB:1:500-1:1000 ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: | AKT3 AKT1 10000 207 208 AKT3_HUMAN AKT1_HUMAN AKT2_HUMAN |
| Specificity: | A synthetic phosphorylated peptide around T308 of human AKTAKT1 (NP_005154.2). |
| Immunogen Sequence: | MKTFC |
| Tissue Specificity | Q9Y243 - In adult tissues, it is highly expressed in brain, lung and kidney, but weakly in heart, testis and liver. In fetal tissues, it is highly expressed in heart, liver and brain and not at all in kidney. P31749 - Expressed in prostate cancer and levels increase from the normal to the malignant state (at protein level). Expressed in all human cell types so far analyzed. The Tyr-176 phosphorylated form shows a significant increase in expression in breast cancers during the progressive stages i.e. normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages. P31751 - Widely expressed. Expressed in myoblasts. Q9Y243 - In adult tissues, it is highly expressed in brain, lung and kidney, but weakly in heart, testis and liver. In fetal tissues, it is highly expressed in heart, liver and brain and not at all in kidney. P31749 - Expressed in prostate cancer and levels increase from the normal to the malignant state (at protein level). Expressed in all human cell types so far analyzed. The Tyr-176 phosphorylated form shows a significant increase in expression in breast cancers during the progressive stages i.e. normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages. P31751 - Widely expressed. Expressed in myoblasts. |
| Alternative Antibody Names | Anti-Rac-Gamma Serine/Threonine-Protein Kinase antibody Anti-Protein Kinase Akt-3 antibody Anti-Protein Kinase B Gamma antibody Anti-Pkb Gamma antibody Anti-Rac-Pk-Gamma antibody Anti-Stk-2 antibody Anti-AKT3 antibody Anti-PKBG antibody Anti-Rac-Alpha Serine/Threonine-Protein Kinase antibody Anti-Protein Kinase B antibody Anti-Pkb antibody Anti-Protein Kinase B Alpha antibody Anti-Pkb Alpha antibody Anti-Proto-Oncogene C-Akt antibody Anti-Rac-Pk-Alpha antibody Anti-AKT1 antibody Anti-PKB antibody Anti-RAC antibody Anti-Rac-Beta Serine/Threonine-Protein Kinase antibody Anti-Protein Kinase Akt-2 antibody Anti-Protein Kinase B Beta antibody Anti-Pkb Beta antibody Anti-Rac Protein Kinase Beta antibody Anti-Rac-Pk-Beta antibody Anti-AKT2 antibody Anti-Rac-Gamma Serine/Threonine-Protein Kinase antibody Anti-Protein Kinase Akt-3 antibody Anti-Protein Kinase B Gamma antibody Anti-Pkb Gamma antibody Anti-Rac-Pk-Gamma antibody Anti-Stk-2 antibody Anti-AKT3 antibody Anti-PKBG antibody Anti-Rac-Alpha Serine/Threonine-Protein Kinase antibody Anti-Protein Kinase B antibody Anti-Pkb antibody Anti-Protein Kinase B Alpha antibody Anti-Pkb Alpha antibody Anti-Proto-Oncogene C-Akt antibody Anti-Rac-Pk-Alpha antibody Anti-AKT1 antibody Anti-PKB antibody Anti-RAC antibody Anti-Rac-Beta Serine/Threonine-Protein Kinase antibody Anti-Protein Kinase Akt-2 antibody Anti-Protein Kinase B Beta antibody Anti-Pkb Beta antibody Anti-Rac Protein Kinase Beta antibody Anti-Rac-Pk-Beta antibody Anti-AKT2 antibody |
Information sourced from Uniprot.org